NucleoCapture device

DEVICE3 trials

Sponsors

Santersus AG, Liverpool University Hospitals NHS Foundation Trust

Conditions

Acute PancreatitisOrgan Failure, MultipleRespiratory FailureSepsisSepsis-associated AKI

Unknown Phase

Effect of Extracorporeal Adsorption of Plasma Neutrophil Extracellular Traps (NET) in Sepsis

CompletedNCT04749238

Santersus AGSepsis, Sepsis-associated AKI

Start: 2021-01-26End: 2021-10-24Updated: 2022-12-06

Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis

Not yet recruitingNCT05647096

Santersus AGRespiratory Failure, Sepsis

Start: 2025-07-01End: 2027-05-28Target: 73Updated: 2024-11-29

Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis

Not yet recruitingNCT06566638

Liverpool University Hospitals NHS Foundation TrustAcute Pancreatitis, Organ Failure, Multiple

Start: 2025-12-01End: 2027-04-01Target: 20Updated: 2025-03-20